Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ETV5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FAM212A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPATA5L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP3A7-CYP3A51P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIBADH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZUFSP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SAMSN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FCGR2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TMCO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NKX6-1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GTF3C4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SETD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHTF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00934 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RRAD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TASP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on